Yuming Jiang to Chemotherapy, Adjuvant
This is a "connection" page, showing publications Yuming Jiang has written about Chemotherapy, Adjuvant.
Connection Strength
2.162
-
Jiang Y, Li T, Liang X, Hu Y, Huang L, Liao Z, Zhao L, Han Z, Zhu S, Wang M, Xu Y, Qi X, Liu H, Yang Y, Yu J, Liu W, Cai S, Li G. Association of Adjuvant Chemotherapy With Survival in Patients With Stage II or III Gastric Cancer. JAMA Surg. 2017 Jul 19; 152(7):e171087.
Score: 0.506
-
Chen Y, Sun Z, Yin J, Ahmad MU, Zhou Z, Feng W, Yang F, Zhou K, Xie J, Bie C, Chen H, Jiang Y. Digital assessment of tertiary lymphoid structures and therapeutic responses in gastric cancer: a multicentric retrospective study. Int J Surg. 2024 Oct 01; 110(10):6732-6747.
Score: 0.208
-
Jiang Y, Zhang Z, Wang W, Huang W, Chen C, Xi S, Ahmad MU, Ren Y, Sang S, Xie J, Wang JY, Xiong W, Li T, Han Z, Yuan Q, Xu Y, Xing L, Poultsides GA, Li G, Li R. Biology-guided deep learning predicts prognosis and cancer immunotherapy response. Nat Commun. 2023 Aug 23; 14(1):5135.
Score: 0.193
-
Jiang Y, Zhou K, Sun Z, Wang H, Xie J, Zhang T, Sang S, Islam MT, Wang JY, Chen C, Yuan Q, Xi S, Li T, Xu Y, Xiong W, Wang W, Li G, Li R. Non-invasive tumor microenvironment evaluation and treatment response prediction in gastric cancer using deep learning radiomics. Cell Rep Med. 2023 Aug 15; 4(8):101146.
Score: 0.192
-
Jiang Y, Jin C, Yu H, Wu J, Chen C, Yuan Q, Huang W, Hu Y, Xu Y, Zhou Z, Fisher GA, Li G, Li R. Development and Validation of a Deep Learning CT Signature to Predict Survival and Chemotherapy Benefit in Gastric Cancer: A Multicenter, Retrospective Study. Ann Surg. 2021 Dec 01; 274(6):e1153-e1161.
Score: 0.171
-
Jiang Y, Liang X, Han Z, Wang W, Xi S, Li T, Chen C, Yuan Q, Li N, Yu J, Xie Y, Xu Y, Zhou Z, Poultsides GA, Li G, Li R. Radiographical assessment of tumour stroma and treatment outcomes using deep learning: a retrospective, multicohort study. Lancet Digit Health. 2021 Jun; 3(6):e371-e382.
Score: 0.165
-
Jiang Y, Xie J, Huang W, Chen H, Xi S, Li T, Chen C, Sun Z, Hu Y, Liu W, Yu J, Zhou Z, Cai S, Li G. Chemotherapy Use and Survival Among Young and Middle-Aged Patients With Gastric Cancer. Clin Transl Gastroenterol. 2020 Oct; 11(10):e00253.
Score: 0.158
-
Jiang Y, Wang H, Wu J, Chen C, Yuan Q, Huang W, Li T, Xi S, Hu Y, Zhou Z, Xu Y, Li G, Li R. Noninvasive imaging evaluation of tumor immune microenvironment to predict outcomes in gastric cancer. Ann Oncol. 2020 Jun; 31(6):760-768.
Score: 0.152
-
Jiang Y, Xie J, Huang W, Chen H, Xi S, Han Z, Huang L, Lin T, Zhao LY, Hu YF, Yu J, Cai SR, Li T, Li G. Tumor Immune Microenvironment and Chemosensitivity Signature for Predicting Response to Chemotherapy in Gastric Cancer. Cancer Immunol Res. 2019 Dec; 7(12):2065-2073.
Score: 0.148
-
Jiang Y, Xie J, Han Z, Liu W, Xi S, Huang L, Huang W, Lin T, Zhao L, Hu Y, Yu J, Zhang Q, Li T, Cai S, Li G. Immunomarker Support Vector Machine Classifier for Prediction of Gastric Cancer Survival and Adjuvant Chemotherapeutic Benefit. Clin Cancer Res. 2018 Nov 15; 24(22):5574-5584.
Score: 0.136
-
Jiang Y, Zhang Q, Hu Y, Li T, Yu J, Zhao L, Ye G, Deng H, Mou T, Cai S, Zhou Z, Liu H, Chen G, Li G, Qi X. ImmunoScore Signature: A Prognostic and Predictive Tool in Gastric Cancer. Ann Surg. 2018 Mar; 267(3):504-513.
Score: 0.132